Client: Global Scientific Publisher (Oncology Journal) Challenge: Identifying and engaging high-quality authors in a competitive research landscape Solution: AI-driven Author Outreach combining lead generation, validation, and targeted engagement Impact: 563 high-quality author leads identified and validated 60% email open rate with 99% delivery success Successful onboarding of new authors to the journal
The Challenge
A leading scientific publisher sought to strengthen its oncology journal by attracting high-quality, domain-specific research contributions.
However, identifying and engaging the right authors presented several challenges:
Difficulty in discovering emerging researchers across fragmented sources such as preprint repositories
Limited visibility into high-potential authors prior to formal publication
Risk of low engagement from generic outreach campaigns
Need to maintain credibility and avoid spam-like communication
The publisher required a targeted, scalable outreach strategy to connect with the right authors and drive meaningful engagement.
The Solution
Molecular Connections implemented an AI-driven Author Outreach framework, combining machine learning, domain expertise, and campaign automation to deliver precision-led author engagement.
This approach transformed traditional outreach into a data-driven acquisition funnel.
Author Outreach Framework
Targeted Author Discovery: Identified high-potential authors from preprint repositories (e.g., bioRxiv, medRxiv) and other relevant sources, enabling early engagement with emerging research contributors.
ML-Driven Lead Qualification: Applied machine learning models to filter and prioritize authors based on domain relevance, publication history, and alignment with journal scope.
Expert Validation Layer: Oncology subject matter experts validated shortlisted authors to ensure quality, relevance, and adherence to journal standards.
Personalized Outreach Campaigns: Executed tailored email campaigns with advanced tracking, ensuring high deliverability and engagement while maintaining professional credibility.
Automated Re-engagement: Deployed structured reminder campaigns to reconnect with high-value authors who had not responded initially, improving overall conversion.
Impact Delivered
The Author Outreach framework enabled the publisher to significantly improve both the quality and effectiveness of its author acquisition efforts.
Identified and engaged 563 qualified oncology authors
Achieved a 60% email open rate and 99% delivery rate
Generated strong engagement through targeted, personalized outreach
Successfully onboarded new authors aligned with journal scope
Established a repeatable, scalable model for author acquisition
Related Case Studies
Advancing Systems Biology and Drug Discovery with the NetPro™ Protein Interaction Knowledgebase
150,000+ Interactions
Molecular Connections developed and continuously enhanced NetPro™, a manually curated protein interaction knowledgebase designed to support systems biology, pathway analysis, and drug discovery initiatives. Leveraged by leading academic and research institutions including University of California, Los Angeles, the platform combined high-quality curated interaction data with kinetic, mutation, and knockout intelligence to enable deeper biological insights and accelerate in-silico target discovery.
Accelerating Biomedical Intelligence with AI-Powered Text Mining and Data Normalization Using the Bio-In™ Platform
!3,500 Clinical Trial Entries
Pharmaceutical organizations faced growing challenges in extracting actionable intelligence from rapidly expanding biomedical data sources including literature, clinical trials, patents, news, and conference abstracts. Molecular Connections developed the Bio-In™ platform, an AI-powered biomedical text mining and normalization solution that aggregates, structures, and delivers analytics-ready biomedical intelligence to accelerate research and decision-making.
Accelerating Target Discovery Through AI-Enabled Gene–Disease Association Knowledgebase Development
~30,000 Articles Analyzed
A leading U.S.-based pharmaceutical company required a comprehensive, searchable knowledgebase to support target identification and prioritization efforts across epigenetic research programs. Molecular Connections developed a highly curated gene–disease association platform by extracting, normalizing, and semantically structuring data from scientific literature, patents, and proprietary resources, enabling faster and more informed research decisions.
